Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Dec 1;90(23):11079–11083. doi: 10.1073/pnas.90.23.11079

TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility.

D G Jackson 1, J D Capra 1
PMCID: PMC47925  PMID: 8248212

Abstract

It has been previously demonstrated that individuals with certain DR alleles have an increased relative risk of developing insulin-dependent diabetes mellitus (IDDM). The disease association is even stronger with certain DQ alleles but there is little association with DP providing a boundary of disease association to the 430 kb between DQ and DP. The recently described TAP (transporter associated with antigen processing) genes have been mapped approximately midway between DP and DQ. Therefore, it was of interest to determine if any TAP alleles were associated with IDDM. In addition to the alleles of TAP1 that have been described, others were identified during this study. Diabetics and normal controls were screened for TAP1 using single-stranded conformational polymorphism and relative risk was determined. In the same population group we have studied extensively in the past, we found a higher association of a TAP1 allele with IDDM than with any single HLA-DP allele but the risk was lower than with HLA-DQB1*0302. These data provide new limits for IDDM susceptibility to the 190-kb interval between TAP1 and HLA-DQB1.

Full text

PDF
11079

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Awdeh Z., Yunis E. J. Conserved, extended MHC haplotypes. Exp Clin Immunogenet. 1992;9(2):58–71. [PubMed] [Google Scholar]
  2. Anderson M. P., Gregory R. J., Thompson S., Souza D. W., Paul S., Mulligan R. C., Smith A. E., Welsh M. J. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991 Jul 12;253(5016):202–205. doi: 10.1126/science.1712984. [DOI] [PubMed] [Google Scholar]
  3. Attaya M., Jameson S., Martinez C. K., Hermel E., Aldrich C., Forman J., Lindahl K. F., Bevan M. J., Monaco J. J. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature. 1992 Feb 13;355(6361):647–649. doi: 10.1038/355647a0. [DOI] [PubMed] [Google Scholar]
  4. Bach F. H., Rich S. S., Barbosa J., Segall M. Insulin-dependent diabetes--associated HLA-D region encoded determinants. Hum Immunol. 1985 Feb;12(2):59–64. doi: 10.1016/0198-8859(85)90343-x. [DOI] [PubMed] [Google Scholar]
  5. Bahram S., Arnold D., Bresnahan M., Strominger J. L., Spies T. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10094–10098. doi: 10.1073/pnas.88.22.10094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baisch J. M., Capra J. D. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: association maps telomeric to HLA-DP. Scand J Immunol. 1992 Aug;36(2):331–340. doi: 10.1111/j.1365-3083.1992.tb03106.x. [DOI] [PubMed] [Google Scholar]
  7. Baisch J. M., Capra J. D. Linkage disequilibrium within the HLA complex does not extend into HLA-DP. Scand J Immunol. 1993 Apr;37(4):499–503. doi: 10.1111/j.1365-3083.1993.tb03325.x. [DOI] [PubMed] [Google Scholar]
  8. Baisch J. M., Capra J. D. Second class distinction. Curr Biol. 1991 Dec;1(6):385–387. doi: 10.1016/0960-9822(91)90201-7. [DOI] [PubMed] [Google Scholar]
  9. Baisch J. M., O'Brien M. E., Hoover M. L., Capra J. D. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: HLA-DQ alpha complements HLA-DQ beta. Scand J Immunol. 1992 Aug;36(2):321–330. doi: 10.1111/j.1365-3083.1992.tb03105.x. [DOI] [PubMed] [Google Scholar]
  10. Baisch J. M., Weeks T., Giles R., Hoover M., Stastny P., Capra J. D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 1990 Jun 28;322(26):1836–1841. doi: 10.1056/NEJM199006283222602. [DOI] [PubMed] [Google Scholar]
  11. Beier D. R., Dushkin H., Sussman D. J. Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9102–9106. doi: 10.1073/pnas.89.19.9102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T. Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens. 1992 Apr;39(4):161–173. doi: 10.1111/j.1399-0039.1992.tb01932.x. [DOI] [PubMed] [Google Scholar]
  13. Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
  14. Carrington M., Miller T., White M., Gerrard B., Stewart C., Dean M., Mann D. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum Immunol. 1992 Mar;33(3):208–212. doi: 10.1016/0198-8859(92)90073-v. [DOI] [PubMed] [Google Scholar]
  15. Ceman S., Rudersdorf R., Long E. O., Demars R. MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J Immunol. 1992 Aug 1;149(3):754–761. [PubMed] [Google Scholar]
  16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  17. Colonna M., Bresnahan M., Bahram S., Strominger J. L., Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3932–3936. doi: 10.1073/pnas.89.9.3932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dorman J. S., LaPorte R. E., Stone R. A., Trucco M. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7370–7374. doi: 10.1073/pnas.87.19.7370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Easteal S., Viswanathan M., Serjeantson S. W. HLA-DP, -DQ and -DR RFLP types in south Indian insulin-dependent diabetes mellitus patients. Tissue Antigens. 1990 Feb;35(2):71–74. doi: 10.1111/j.1399-0039.1990.tb01759.x. [DOI] [PubMed] [Google Scholar]
  20. Faustman D., Li X. P., Lin H. Y., Fu Y. E., Eisenbarth G., Avruch J., Guo J. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science. 1991 Dec 20;254(5039):1756–1761. doi: 10.1126/science.1763324. [DOI] [PubMed] [Google Scholar]
  21. Gaskins H. R., Monaco J. J., Leiter E. H. Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice. Science. 1992 Jun 26;256(5065):1826–1831. doi: 10.1126/science.1352067. [DOI] [PubMed] [Google Scholar]
  22. Henson V., Maclaren N., Riley W., Wakeland E. K. Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals. Immunogenetics. 1987;25(3):152–160. doi: 10.1007/BF00344028. [DOI] [PubMed] [Google Scholar]
  23. Holton T. A., Graham M. W. A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic Acids Res. 1991 Mar 11;19(5):1156–1156. doi: 10.1093/nar/19.5.1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hänninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest. 1992 Nov;90(5):1901–1910. doi: 10.1172/JCI116067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Juranka P. F., Zastawny R. L., Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J. 1989 Dec;3(14):2583–2592. doi: 10.1096/fasebj.3.14.2574119. [DOI] [PubMed] [Google Scholar]
  26. Kleijmeer M. J., Kelly A., Geuze H. J., Slot J. W., Townsend A., Trowsdale J. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature. 1992 May 28;357(6376):342–344. doi: 10.1038/357342a0. [DOI] [PubMed] [Google Scholar]
  27. Nepom G. T., Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol. 1991;9:493–525. doi: 10.1146/annurev.iy.09.040191.002425. [DOI] [PubMed] [Google Scholar]
  28. Nepom G. T. Immunogenetics of HLA-associated diseases. Concepts Immunopathol. 1988;5:80–105. [PubMed] [Google Scholar]
  29. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  30. Owerbach D., Lernmark A., Platz P., Ryder L. P., Rask L., Peterson P. A., Ludvigsson J. HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature. 1983 Jun 30;303(5920):815–817. doi: 10.1038/303815a0. [DOI] [PubMed] [Google Scholar]
  31. Pazmany L., Rowland-Jones S., Huet S., Hill A., Sutton J., Murray R., Brooks J., McMichael A. Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med. 1992 Feb 1;175(2):361–369. doi: 10.1084/jem.175.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Powis S. H., Mockridge I., Kelly A., Kerr L. A., Glynne R., Gileadi U., Beck S., Trowsdale J. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1463–1467. doi: 10.1073/pnas.89.4.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Powis S. H., Tonks S., Mockridge I., Kelly A. P., Bodmer J. G., Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics. 1993;37(5):373–380. doi: 10.1007/BF00216802. [DOI] [PubMed] [Google Scholar]
  34. Powis S. J., Deverson E. V., Coadwell W. J., Ciruela A., Huskisson N. S., Smith H., Butcher G. W., Howard J. C. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature. 1992 May 21;357(6375):211–215. doi: 10.1038/357211a0. [DOI] [PubMed] [Google Scholar]
  35. Rønningen K. S., Spurkland A., Iwe T., Vartdal F., Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens. 1991 Mar;37(3):105–111. doi: 10.1111/j.1399-0039.1991.tb01854.x. [DOI] [PubMed] [Google Scholar]
  36. Rønningen K. S., Undlien D. E., Ploski R., Maouni N., Konrad R. J., Jensen E., Hornes E., Reijonen H., Colonna M., Monos D. S. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur J Immunol. 1993 May;23(5):1050–1056. doi: 10.1002/eji.1830230511. [DOI] [PubMed] [Google Scholar]
  37. Sette A., Ceman S., Kubo R. T., Sakaguchi K., Appella E., Hunt D. F., Davis T. A., Michel H., Shabanowitz J., Rudersdorf R. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science. 1992 Dec 11;258(5089):1801–1804. doi: 10.1126/science.1465617. [DOI] [PubMed] [Google Scholar]
  38. Sheehy M. J., Rowe J. R., MacDonald M. J. A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes. Diabetes. 1985 Sep;34(9):942–944. doi: 10.2337/diab.34.9.942. [DOI] [PubMed] [Google Scholar]
  39. Spies T., Bresnahan M., Bahram S., Arnold D., Blanck G., Mellins E., Pious D., DeMars R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990 Dec 20;348(6303):744–747. doi: 10.1038/348744a0. [DOI] [PubMed] [Google Scholar]
  40. Spies T., Cerundolo V., Colonna M., Cresswell P., Townsend A., DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature. 1992 Feb 13;355(6361):644–646. doi: 10.1038/355644a0. [DOI] [PubMed] [Google Scholar]
  41. Spies T., DeMars R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature. 1991 May 23;351(6324):323–324. doi: 10.1038/351323a0. [DOI] [PubMed] [Google Scholar]
  42. Sterkers G., Zeliszewski D., Chaussée A. M., Deschamps I., Font M. P., Freidel C., Hors J., Betuel H., Dausset J., Levy J. P. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6473–6477. doi: 10.1073/pnas.85.17.6473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Thomson G., Robinson W. P., Kuhner M. K., Joe S., MacDonald M. J., Gottschall J. L., Barbosa J., Rich S. S., Bertrams J., Baur M. P. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 1988 Dec;43(6):799–816. [PMC free article] [PubMed] [Google Scholar]
  44. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  45. Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A., Kelly A. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 1990 Dec 20;348(6303):741–744. doi: 10.1038/348741a0. [DOI] [PubMed] [Google Scholar]
  46. Trowsdale J., Ragoussis J., Campbell R. D. Map of the human MHC. Immunol Today. 1991 Dec;12(12):443–446. doi: 10.1016/0167-5699(91)90017-n. [DOI] [PubMed] [Google Scholar]
  47. Van Kaer L., Ashton-Rickardt P. G., Ploegh H. L., Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell. 1992 Dec 24;71(7):1205–1214. doi: 10.1016/s0092-8674(05)80068-6. [DOI] [PubMed] [Google Scholar]
  48. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  49. Yamagata K., Hanafusa T., Nakajima H., Sada M., Amemiya H., Tomita K., Miyagawa J., Noguchi T., Tanaka T., Kono N. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in Japanese. Tissue Antigens. 1991 Sep;38(3):107–110. doi: 10.1111/j.1399-0039.1991.tb02022.x. [DOI] [PubMed] [Google Scholar]
  50. van Endert P. M., Lopez M. T., Patel S. D., Monaco J. J., McDevitt H. O. Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11594–11597. doi: 10.1073/pnas.89.23.11594. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES